SyNergy - Cluster for Systems Neurology: The better way to manage your data
Free and open platform for easier research data management
Latest additions
- Proteomics
Snapshot - added 24 days ago - NDP52 interactome
Data file - added 24 days ago - Shotgun proteomics
Assay - added 24 days ago - NDP52 interactome
Study - added 24 days ago - TAPL interaction network - Lysosomal targeting of the ABC transporter TAPL is determined by membrane localized charged residues
Data file - added 24 days ago - Affinity purification coupled with mass spectrometry proteomics
Assay - added 24 days ago - Lysosomal targeting of TAPL
Study - added 24 days ago - Interactome of overexpressed BAG3 in HEK293T cells
Data file - added 24 days ago - Affinity purification coupled with mass spectrometry proteomics
Assay - added 24 days ago - BAG3-mediated autophagy
Study - added 24 days ago
Find content
There are not yet any tags defined
Neurological diseases are on the rise – and as societies age, they affect an ever-increasing number of people, not only in Europe, but worldwide.
The Munich Cluster for Systems Neurology (SyNergy) investigates how complex neurological diseases such as Alzheimer's disease, stroke, and multiple sclerosis develop. Even though these diseases differ in their clinical manifestations, overlapping mechanisms are involved in their development. For example, the immune system gets activated in dementia, while brain inflammation can cause nerve cells and their supporting glial cells to degenerate.
Using systems neurology as a new interdisciplinary approach, researchers can decipher the shared disease mechanisms of neurovascular, neurodegenerative, and neuroimmunological diseases and on this basis develop novel diagnostic and therapeutic approaches.
SyNergy has been funded as an Excellence Cluster by the German Research Foundation (DFG) since 2012.